RTC13
Modify Date: 2024-01-02 11:27:51
RTC13 structure
|
Common Name | RTC13 | ||
|---|---|---|---|---|
| CAS Number | 1359825-94-7 | Molecular Weight | 315.30 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H9N3O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RTC13RTC13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy (DMD)[1]. |
| Name | RTC13 |
|---|---|
| Synonym | More Synonyms |
| Description | RTC13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy (DMD)[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Animal Model: Wild-type (C57BL/10) mice at 10 to 12 weeks of age[1]. Dosage: 10 (n = 5), 30 (n = 5), 60 (n = 5) or 300 mg/kg (n = 5). Administration: Intraperitoneal Administration. Result: No changes were observed in liver and kidney weights at the time of necropsies, and Hematoxylin and Eosin (H&E) staining revealed the absence of histopathological changes. |
| References |
| Molecular Formula | C14H9N3O4S |
|---|---|
| Molecular Weight | 315.30 |
| Exact Mass | 315.03100 |
| PSA | 139.71000 |
| LogP | 3.44290 |
| (5Z)-2-Amino-5-[[5-(2-nitrophenyl)-2-furanyl]methylene]-4(5H)-thiazolone |
| (Z)-2-amino-5-((5-(2-nitrophenyl)furan-2-yl)methylene)thiazol-4(5H)-one |
| 4(5H)-Thiazolone, 2-amino-5-[[5-(2-nitrophenyl)-2-furanyl]methylene]-, (5Z)- |